Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02806739 · ClinicalTrials.gov registry record · Early Phase 1
Soy Supplementation and Gestational Diabetes
A Early Phase 1 study of Gestational Diabetes, sponsored by University of Massachusetts, Boston.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT02806739 is a Early Phase 1 study of Gestational Diabetes that has completed, run by University of Massachusetts, Boston. The registered enrollment target is 40 participants, below the 321-participant average among 41 other Gestational Diabetes trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02806739, a Early Phase 1 study of Gestational Diabetes, has completed, sponsored by University of Massachusetts, Boston.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess the feasibility of randomizing pregnant women at high risk for gestational diabetes to a 24-week period of soy food consumption. This study will also examine the effects of soy protein and isoflavones on glucose metabolism and lipid levels among pregnant women at high risk for gestational diabetes, and on child's weight and height at birth and 6 weeks of life.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Soy Group (Soy Protein + Isoflavones)
- DIETARY_SUPPLEMENT Control Group (Minimize Soy Intake)
Study Locations (1)
Massachusetts
- Tufts Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2013-01 |
| Est. Completion | 2016-09 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02806739
The ClinicalTrials.gov registry entry for NCT02806739 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 321-participant average among 41 other Gestational Diabetes trials with a reported enrollment target (88% lower). The listed sponsor is University of Massachusetts, Boston, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Gestational Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Soy Group (Soy Protein + Isoflavones) is the first listed.
NCT02806739 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02806739 about?
NCT02806739 is a clinical study titled "Soy Supplementation and Gestational Diabetes". The purpose of this study is to assess the feasibility of randomizing pregnant women at high risk for gestational diabetes to a 24-week period of soy food consumption. This study will also examine the effects of soy protein and isoflavones on glucose metabolism and lipid levels among pregnant women ...
What is the current status of trial NCT02806739?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 40 participants. The study started on 2013-01. Estimated completion is 2016-09.
What conditions does trial NCT02806739 study?
This clinical trial studies the following conditions: Gestational Diabetes.
What interventions are being tested in trial NCT02806739?
The interventions under investigation include: Soy Group (Soy Protein + Isoflavones) (DIETARY_SUPPLEMENT), Control Group (Minimize Soy Intake) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02806739?
This trial is sponsored by University of Massachusetts, Boston, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02806739 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gestational Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Role of ET-1, Physical Activity, and Sedentary Behavior in Microvascular Dysfunction Following GDM
RECRUITING · Early Phase 1
-
Oxidative Stress in Microvascular Dysfunction Following Gestational Diabetes
RECRUITING · Early Phase 1
-
Role of NADPH Oxidase in Microvascular Dysfunction Following GDM
RECRUITING · Early Phase 1
-
Metformin for the Treatment of Microvascular Dysfunction After Gestational Diabetes
RECRUITING · Early Phase 1
-
Nutrition Optimization and Community Upliftment for Postpartum Recovery
RECRUITING · NA
-
Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes (START 2)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.